Bevers Denise 4
4 · Kindred Biosciences, Inc. · Filed Feb 23, 2021
Insider Transaction Report
Form 4
Bevers Denise
Chief Operating Officer
Transactions
- Sale
Common Stock
2021-02-22$5.00/sh−4,622$23,110→ 0 total(indirect: By SD Scientific, Inc.) - Sale
Common Stock
2021-02-19$5.00/sh−5$25→ 0 total(indirect: By SD Scientific, Inc.) - Exercise/Conversion
Stock Option (right to buy)
2021-02-19−5→ 13,081 total(indirect: By SD Scientific, Inc.)Exercise: $0.32From: 2013-05-09Exp: 2023-05-09→ Common Stock (5 underlying) - Exercise/Conversion
Common Stock
2021-02-19$0.32/sh+5$2→ 5 total(indirect: By SD Scientific, Inc.) - Exercise/Conversion
Common Stock
2021-02-22$0.32/sh+4,622$1,479→ 4,622 total(indirect: By SD Scientific, Inc.) - Exercise/Conversion
Stock Option (right to buy)
2021-02-22−4,622→ 8,396 total(indirect: By SD Scientific, Inc.)Exercise: $0.32From: 2013-05-09Exp: 2023-05-09→ Common Stock (4,622 underlying)
Holdings
- 143,835
Common Stock
Footnotes (2)
- [F1]Held by SD Scientific, Inc. ("SD Scientific"). The Reporting Person is a co-director and co-stockholder of SD Scientific and, as such shares voting and dispositive power over such shares held by SD Scientific but disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2020.